ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank

New Post Public Reply Private Reply Replies (0) Message Board
louied91
122
ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman

https://www.businesswire.com/news/home/202608...e-Chairman

Dr. Kim will advise on international partnerships and global access initiatives through the newly formed Office of the Executive Chairman

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that Dr. Jim Yong Kim has joined the company as Vice Chairman. Dr. Kim will serve in a newly created Office of the Executive Chairman, where he will focus on strengthening the company's international and global relationships. He will report to Executive Chairman and Founder Dr. Patrick Soon-Shiong.

The Office of the Executive Chairman will bring together senior leaders to support Dr. Soon-Shiong on strategy, partnerships, and initiatives intended to advance ImmunityBio’s scientific and clinical programs globally. In his role, Dr. Kim will focus on relationships with governments, health ministries, multilateral institutions, and global health partners, with the goal of supporting access to the company’s immunotherapy platform, clinical programs, and approved therapies where authorized in markets outside the United States.

Dr. Kim brings decades of leadership at the intersection of medicine, public health, development, and global finance. He served as the twelfth president of the World Bank Group from 2012 to 2019, where he set the institution's goals to end extreme poverty by 2030 and to lift up the poorest 40 percent of people in developing countries. During his tenure, the World Bank launched the Pandemic Emergency Financing Facility, one of the first financial instruments built to move money quickly to stop outbreaks before they spread.

In 1987, Dr. Kim co-founded Partners In Health with Dr. Paul Farmer and others, and helped build treatment programs for drug resistant tuberculosis, HIV, and AIDS in some of the poorest communities in Haiti, Peru, and beyond. From 2003 to 2005, he led the World Health Organization's HIV/AIDS department, where he directed the "3 by 5" initiative, the first global target for AIDS treatment, which expanded access to antiretroviral medicines across the developing world. He has also served as president of Dartmouth College and held professorships at Harvard Medical School and the Harvard T.H. Chan School of Public Health. A physician and anthropologist, he is a recipient of a MacArthur Fellowship and was named one of TIME magazine's 100 Most Influential People. He currently serves as Vice Chairman and Senior Advisor at Global Infrastructure Partners, a part of Blackrock, where he supports the work of the emerging markets team. He also serves as the Chancellor of the University of Global Health Equity in Rwanda.

“Dr. Kim has spent his life working to bring care to people and communities that too often face the greatest barriers to access,” said Dr. Patrick Soon-Shiong, Founder, Executive Chairman, and Global Chief Scientific and Medical Officer of ImmunityBio. “Our mission is to harness the power of the immune system to address some of the world’s most challenging diseases. Dr. Kim’s experience across global health, development finance, governments, and multilateral institutions will be invaluable as we work to build the partnerships that can help advance our science, support clinical development, and expand access to our approved therapies around the world.”

“I have spent my career focused on ensuring that scientific and medical advances reach the people who need them most,” said Dr. Jim Yong Kim. “ImmunityBio is pursuing an ambitious vision grounded in immunology, innovation, and global impact that has the potential to improve countless lives. I am excited to work with Dr. Soon-Shiong and the team to build partnerships across governments, health system, and international institutions that can help accelerate research, broaden access and bring the benefits of these advances to patients around the world.” 

ImmunityBio Inc. (IBRX) Stock Research Links

IBRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 67

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
NextPlat’s 150-Patient Test Has a Long Road Ahead

Updated Category News Views 114

A strip of pills can look mundane, yet it is where this entire NextPlat pitch either earns its keep or falls apart. PharmcoRx has signed a partner pharmacy agreement with MedSure Systems for a 150-patient Medicare medication-adherence pilot in South Florida. That is a small starting line, no two ways around it. Still, the mechanics are more interesting than another vague...

Continue Reading
Eight O'Clock Adds Blonde Roast Pods to Its Lineup

Updated Category News Views 149

A lighter cup of coffee just became Eight O'Clock Coffee's newest swing at the single-serve shelf. On Nov. 19, 2026, the company said it introduced Blonde Roast K-Cup pods, a bright and smooth option aimed at drinkers who prefer a lighter roast. The product is available through Keurig.com and Amazon. That is the whole announcement, and frankly it is better to keep it that...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
HLRBO's Data-Heavy Rebuild Changes Hunting Lease Market

Updated Category News Views 149

A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...

Continue Reading
PetSmart Charities Adds Strategy Role for Pet Families

Updated Category News Views 110

A pet bowl can become a crisis marker faster than people admit. Housing trouble, empty cupboards, a hurricane, or an unaffordable veterinary bill can turn a loved animal into one more impossible responsibility. That is the uncomfortable reality behind PetSmart Charities' decision to create a vice president of strategic programs and partnerships role and appoint Heather...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 156

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Stowers Brings a Transformation CTO Into Its Lab

Updated Category News Views 31

Data Has Become Lab Infrastructure Microscopes may get the glory, but the plumbing behind modern biology is increasingly digital, sprawling and unforgiving. That is why Stowers Institute for Medical Research appointing Brandon Mayer as vice president and chief technology officer on November 19, 2026, deserves more attention than the usual executive-shuffle treatment. This...

Continue Reading
Health In Tech Gets a Real Distribution Test in 2027

Updated Category News Views 190

A 100,000-employee funnel is the sort of number that makes a small InsurTech investor sit up, then reach for the fine print. Health In Tech has brought a national third-party administrator onto its eDIYBS platform, giving the company access to a TPA serving more than 650 employers in over 40 states, with more than 100,000 covered employees as of May 2026. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Hexagon Agility Nets Record $100M Order from Certarus

Updated Category News Views 79

Hexagon Agility and Certarus: A Major Deal Secured There ain't nothing like landing a big fish in the business world, and Hexagon Agility just hooked a whopper. This major player in clean fuel solutions secured an order from Certarus worth a hefty $100 million. For those who keep tabs, that's Hexagon's largest order for Mobile Pipeline® modules to date, and it's all...

Continue Reading
Performance Food Group Co's Earnings: What to Expect

Updated Category News Views 111

Preparing for Performance Food Group Co's Earnings Report Performance Food Group Co PFGC is on the verge of releasing its latest quarterly earnings report. Investors are keen to know what to anticipate ahead of this significant announcement. Expectations for Earnings Performance Analysts anticipate that Performance Food Group Co will report an earnings per share (EPS) of...

Continue Reading
Innovative Collaboration Transforms Healthcare for Incarcerated Patients

Updated Category News Views 360

Innovative Partnership Shaping Correctional Healthcare Armor Health is embarking on a transformative journey in correctional healthcare through an exciting partnership with Antidote-AI, set to significantly enhance the services provided to incarcerated individuals. This collaboration brings advanced artificial intelligence (AI) capabilities to the forefront of a critical...

Continue Reading
Celebrating Innovation: A Journey Through 17 Years of Left Field Labs

Updated Category News Views 405

Left Field Labs Marks 17 Years of Innovation and Growth Left Field Labs, a creative technology agency within Stagwell (NASDAQ: STGW), celebrates its 17th anniversary with impressive revenue growth and a diverse global client base. This celebration highlights its commitment to delivering transformative digital experiences using advanced AI technologies. Transformative...

Continue Reading
Leadership Changes at Humphreys Capital Pave New Pathway

Updated Category News Views 465

Humphreys Capital's Leadership Transition Overview Humphreys Capital, a prominent institutional investment manager, has announced significant changes in its leadership team. This transition includes the appointment of Grant Humphreys as Chairman of the Board of Directors, succeeding his father, Kirk Humphreys, who will continue his involvement as Chairman Emeritus. Blair...

Continue Reading